Ernesto Bertarelli

Current Company

Serono / Waypoint Capital — Former CEO

The Biotech Fortune Built on Fertility Science

Ernesto Bertarelli inherited the leadership of Ares-Serono, the Geneva-based pharmaceutical company his father had built, and transformed it from a niche player in reproductive medicine into a global biotechnology powerhouse. Under his leadership as CEO from 1996 to 2007, Serono developed and commercialized treatments that helped millions of couples conceive through in vitro fertilization, while simultaneously building a portfolio of drugs for neurological conditions — most notably Rebif, which became one of the leading treatments for relapsing-remitting multiple sclerosis. Bertarelli's strategic vision was to position Serono at the intersection of biotechnology and endocrinology, leveraging the company's deep expertise in hormone-based therapies to develop treatments for conditions where hormonal signaling plays a critical role.

The sale of Serono to Merck KGaA in 2007 for approximately $13 billion was the culmination of a decade-long transformation that increased the company's revenue fivefold and established it as the third-largest biotechnology company in the world. The transaction made the Bertarelli family one of the wealthiest in Switzerland and provided the capital that would fund Ernesto's subsequent ventures in investment, philanthropy, and competitive sailing. The deal was notable not just for its size but for its strategic logic: Merck KGaA gained a world-class biotechnology platform, while Bertarelli secured a price that reflected the full value of the pipeline and infrastructure he had built.

Sailing, Science, and Ocean Conservation

Bertarelli's victory in the 2003 America's Cup — sailing's most prestigious competition — with Team Alinghi made him only the second European in 152 years to win the Auld Mug, and it established Switzerland, a landlocked country, as a surprising force in international sailing. The campaign required not just enormous financial investment but the same combination of technological innovation, team building, and competitive intensity that had characterized his business career. Bertarelli's involvement in the America's Cup extended the tradition of billionaire sportsmen using competitive sailing as a proving ground for engineering innovation — the boats themselves are technology platforms that push the boundaries of materials science, aerodynamics, and computational fluid dynamics.

The Bertarelli Foundation's focus on marine conservation reflects a personal passion that connects Bertarelli's love of the ocean with his scientific training. The foundation has funded research on marine protected areas, ocean biodiversity, and the impact of climate change on marine ecosystems, partnering with institutions including Imperial College London and the Swiss Federal Institute of Technology. The foundation's work has contributed to the establishment of some of the world's largest marine protected areas, including the British Indian Ocean Territory Marine Reserve, and has generated scientific data that informs international ocean governance policy. Bertarelli's approach to philanthropy mirrors his approach to business: large-scale, scientifically rigorous, and focused on creating impact that will endure beyond any individual's involvement.